Brilinta
New anti-clotting drug performs better than Plavix in study.
Thursday, January 14th, 2010Source: DIA Daily
MedPage Today (1/13, Peck) reported that, “among patients who underwent planned stenting for treatment of acute coronary syndromes, those treated with the investigational antiplatelet agent ticagrelor (Brilinta) had fewer cardiovascular events than patients who received clopidogrel (Plavix).” This “finding emerged from a prespecified subset analysis of the PLATO [...]
